Literature DB >> 9847344

Analysis of murine CD8(+) T-cell clones specific for the Dengue virus NS3 protein: flavivirus cross-reactivity and influence of infecting serotype.

A C Spaulding1, I Kurane, F A Ennis, A L Rothman.   

Abstract

Serotype-cross-reactive dengue virus-specific cytotoxic T lymphocytes (CTL) induced during a primary dengue virus infection are thought to play a role in the immunopathogenesis of dengue hemorrhagic fever (DHF) during a secondary dengue virus infection. Although there is no animal model of DHF, we previously reported that murine dengue virus-specific CTL responses are qualitatively similar to human dengue virus-specific CTL responses. We used BALB/c mice to study the specificity of the CTL response to an immunodominant epitope on the dengue virus NS3 protein. We mapped the minimal H-2Kd-restricted CTL epitope to residues 298 to 306 of the dengue type 2 virus NS3 protein. In short-term T-cell lines and clones, the predominant CD8(+) CTL to this epitope in mice immunized with dengue type 2 virus or vaccinia virus expressing the dengue type 4 virus NS3 protein were cross-reactive with dengue type 2 or type 4 virus, while broadly serotype-cross-reactive CTL were a minority population. In dengue type 3 virus-immunized mice, the predominant CTL response to this epitope was broadly serotype cross-reactive. All of the dengue virus-specific CTL clones studied also recognized the homologous NS3 sequences of one or more closely related flaviviruses, such as Kunjin virus. The critical contact residues for the CTL clones with different specificities were mapped with peptides having single amino acid substitutions. These data demonstrate that primary dengue virus infection induces a complex population of flavivirus-cross-reactive NS3-specific CTL clones in mice and suggest that CTL responses are influenced by the viral serotype. These findings suggest an additional mechanism by which the order of sequential flavivirus infections may influence disease manifestations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9847344      PMCID: PMC103845          DOI: 10.1128/JVI.73.1.398-403.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Complete nucleotide sequence of dengue type 3 virus genome RNA.

Authors:  K Osatomi; H Sumiyoshi
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

2.  The nucleotide sequence of dengue type 4 virus: analysis of genes coding for nonstructural proteins.

Authors:  E Mackow; Y Makino; B T Zhao; Y M Zhang; L Markoff; A Buckler-White; M Guiler; R Chanock; C J Lai
Journal:  Virology       Date:  1987-08       Impact factor: 3.616

3.  A prospective study of dengue infections in Bangkok.

Authors:  D S Burke; A Nisalak; D E Johnson; R M Scott
Journal:  Am J Trop Med Hyg       Date:  1988-01       Impact factor: 2.345

4.  Dengue virus-specific murine T-lymphocyte proliferation: serotype specificity and response to recombinant viral proteins.

Authors:  A L Rothman; I Kurane; Y M Zhang; C J Lai; F A Ennis
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

5.  Sequence analysis of cloned dengue virus type 2 genome (New Guinea-C strain).

Authors:  K Irie; P M Mohan; Y Sasaguri; R Putnak; R Padmanabhan
Journal:  Gene       Date:  1989-02-20       Impact factor: 3.688

6.  Protection against Japanese encephalitis by inactivated vaccines.

Authors:  C H Hoke; A Nisalak; N Sangawhipa; S Jatanasen; T Laorakapongse; B L Innis; S Kotchasenee; J B Gingrich; J Latendresse; K Fukai
Journal:  N Engl J Med       Date:  1988-09-08       Impact factor: 91.245

7.  Sequence of the 3' half of the Murray Valley encephalitis virus genome and mapping of the nonstructural proteins NS1, NS3, and NS5.

Authors:  E Lee; C Fernon; R Simpson; R C Weir; C M Rice; L Dalgarno
Journal:  Virus Genes       Date:  1990-09       Impact factor: 2.332

8.  Complete nucleotide sequence of the Japanese encephalitis virus genome RNA.

Authors:  H Sumiyoshi; C Mori; I Fuke; K Morita; S Kuhara; J Kondou; Y Kikuchi; H Nagamatu; A Igarashi
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

9.  Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production.

Authors:  I Kurane; B L Innis; A Nisalak; C Hoke; S Nimmannitya; A Meager; F A Ennis
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

10.  Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity.

Authors:  I Kurane; A Meager; F A Ennis
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  24 in total

Review 1.  Heterologous immunity between viruses.

Authors:  Raymond M Welsh; Jenny W Che; Michael A Brehm; Liisa K Selin
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine.

Authors:  C Y Huang; S Butrapet; D J Pierro; G J Chang; A R Hunt; N Bhamarapravati; D J Gubler; R M Kinney
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Sculpting the immunological response to dengue fever by polytopic vaccination.

Authors:  Hao Zhou; Michael W Deem
Journal:  Vaccine       Date:  2005-12-28       Impact factor: 3.641

4.  Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design.

Authors:  Rosa Ramírez; Rosabel Falcón; Alienys Izquierdo; Angélica García; Mayling Alvarez; Ana Beatriz Pérez; Yudira Soto; Mayra Muné; Emiliana Mandarano da Silva; Oney Ortega; Ronaldo Mohana-Borges; María G Guzmán
Journal:  Virus Genes       Date:  2014-05-23       Impact factor: 2.332

5.  Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice.

Authors:  Joseph N Brewoo; Richard M Kinney; Tim D Powell; John J Arguello; Shawn J Silengo; Charalambos D Partidos; Claire Y-H Huang; Dan T Stinchcomb; Jorge E Osorio
Journal:  Vaccine       Date:  2011-12-13       Impact factor: 3.641

6.  Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical.

Authors:  Sujan Shresta; Jennifer L Kyle; Heidi M Snider; Manasa Basavapatna; P Robert Beatty; Eva Harris
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

7.  Dengue: A Clinicohaematological Profile.

Authors:  M Banerjee; T Chatterjee; G S Choudhary; V Srinivas; V K Kataria
Journal:  Med J Armed Forces India       Date:  2011-07-21

8.  A protective role for dengue virus-specific CD8+ T cells.

Authors:  Lauren E Yauch; Raphaël M Zellweger; Maya F Kotturi; Afrina Qutubuddin; John Sidney; Bjoern Peters; Tyler R Prestwood; Alessandro Sette; Sujan Shresta
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

9.  Kunjin virus replicon vectors for human immunodeficiency virus vaccine development.

Authors:  Tracey J Harvey; Itaru Anraku; Richard Linedale; David Harrich; Jason Mackenzie; Andreas Suhrbier; Alexander A Khromykh
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

Review 10.  Evasion of the human innate immune system by dengue virus.

Authors:  Sarah Pagni; Ana Fernandez-Sesma
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.